Disclaimer: This compound is provided strictly for Research Use Only (RUO). It is not intended for human consumption, diagnostic procedures, or therapeutic applications. The following content is for educational and laboratory research purposes only.
Semax is a synthetic regulatory peptide derived from the ACTH(4–7) fragment and stabilized with a Pro-Gly-Pro (PGP) sequence. Classified as a neuroactive and cytoprotective peptide, Semax is widely studied in neuroscience and gastroenterology research due to its dual neuroprotective and gastroprotective properties.
Peptide Structure and Molecular Characteristics of Semax
Semax is composed of the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, combining the ACTH(4–7) pharmacophore with a stabilizing PGP motif. This structural modification improves peptide stability and resistance to enzymatic degradation, making Semax suitable for extended laboratory studies.
Analytical validation using RP-HPLC and mass spectrometry confirms the molecular integrity of Semax, supporting its widespread use as a synthetic bioactive peptide in research settings.
Neuroprotective Mechanisms of Regulatory Peptides
Semax exhibits pronounced neuroprotective effects by modulating intracellular signaling pathways involved in neuronal survival. In ischemic and oxidative stress models, the peptide reduces calcium overload and mitigates glutamate-induced excitotoxicity.
These properties are critical for maintaining mitochondrial function and limiting apoptosis, positioning Semax as a valuable tool in neurodegeneration and stroke research.
BDNF and TrkB Signaling in Neuroactive Peptides
One of the most studied actions of Semax is its influence on brain-derived neurotrophic factor (BDNF). Experimental data demonstrate increased BDNF expression and enhanced TrkB receptor phosphorylation following Semax exposure.
Activation of downstream MAPK/ERK and PI3K/Akt pathways promotes synaptic plasticity, neuronal repair, and long-term neuroprotection.
Gene Expression and Peptide-Mediated Cellular Signaling
Transcriptomic analyses reveal that Semax modulates genes associated with inflammation, apoptosis, and vascular stability. In ischemic models, the peptide suppresses pro-inflammatory cytokines while upregulating genes linked to cellular repair.
This coordinated gene regulation supports blood–brain barrier integrity and reduces secondary tissue damage.
Gastroprotective Effects of Bioactive Peptides
Beyond the central nervous system, Semax demonstrates significant gastroprotective activity. Studies in stress-, ethanol-, and NSAID-induced ulcer models show preservation of gastric mucosal integrity.
The peptide improves gastric microcirculation and exhibits local hemostatic properties, contributing to reduced ulcer formation and accelerated mucosal healing.
Laboratory Applications and Research Use of Synthetic Peptides
Semax is widely utilized in in vitro and in vivo research models, including neuronal cell cultures and ischemia-reperfusion studies. Its stability and reproducibility make it a preferred research peptide.
Proper storage and reconstitution protocols ensure consistent experimental outcomes, reinforcing its role in peptide-based laboratory investigations.
References
- Ashmarin I.P. et al. Regulatory peptides and their role in neuroprotection. Peptides.
- Dolotov O.V. et al. Semax-induced modulation of BDNF signaling in experimental ischemia. Neuroscience Letters.
- Gusev E.I., Skvortsova V.I. Peptide-based neuroprotective strategies in stroke models. CNS Drugs.
- PubChem Compound Summary: Semax (CAS 80714-61-0).
- NCBI. ACTH-derived regulatory peptides and neurotrophic mechanisms.